Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer
NCT00881296
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
gemcitabine and carboplatin
DRUG:
Gemcitabine
Sponsor
Hamamatsu University